Lead Product(s) : DTwP-HepB-Hib-IPV Vaccine
Therapeutic Area : Immunology
Study Phase : Phase I/ Phase II
Sponsor : Universitas Padjadjaran
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
November 15, 2024
Lead Product(s) : DTwP-HepB-Hib-IPV Vaccine
Therapeutic Area : Immunology
Highest Development Status : Phase I/ Phase II
Sponsor : Universitas Padjadjaran
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : SARS-CoV-2 Protein Subunit Recombinant Vaccine
Therapeutic Area : Immunology
Study Phase : Phase III
Sponsor : Center for Child Health Universitas Gadjah Mada | Cipto Mangunkusumo Hospital/Department of Child Health, Faculty of Medicine, University of Indonesia | General Hospital of Shenyang Military Region
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine in Healthy Children
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
September 19, 2022
Lead Product(s) : SARS-CoV-2 Protein Subunit Recombinant Vaccine
Therapeutic Area : Immunology
Highest Development Status : Phase III
Sponsor : Center for Child Health Universitas Gadjah Mada | Cipto Mangunkusumo Hospital/Department of Child Health, Faculty of Medicine, University of Indonesia | General Hospital of Shenyang Military Region
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Recombinant Hepatitis B Vaccine
Therapeutic Area : Immunology
Study Phase : Phase III
Sponsor : Hasan Sadikin General Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
August 01, 2022
Lead Product(s) : Recombinant Hepatitis B Vaccine
Therapeutic Area : Immunology
Highest Development Status : Phase III
Sponsor : Hasan Sadikin General Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Hepatitis B Vaccine
Therapeutic Area : Immunology
Study Phase : Phase III
Sponsor : RS Umum Pusat Sanglah
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
August 01, 2022
Lead Product(s) : Hepatitis B Vaccine
Therapeutic Area : Immunology
Highest Development Status : Phase III
Sponsor : RS Umum Pusat Sanglah
Deal Size : Inapplicable
Deal Type : Inapplicable